A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

ClinicalTrials.gov ID: NCT06626919

Public ClinicalTrials.gov record NCT06626919. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID: NCT06626919
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: Arcellx, Inc.; Industry
Enrollment: 30 participants

Conditions and interventions

Conditions

Interventions

Standard Lymphodepletion regimen Drug
anito-cel Biological

Drug · Biological

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 29, 2025
Primary completion: Feb 28, 2027
Completion: Mar 31, 2028
Last update posted: Feb 24, 2026

2025 – 2028

United States locations

U.S. sites: 13
U.S. states: 9
U.S. cities: 13

Facility	City	State	ZIP	Site status
UCLA Medical Center	Los Angeles	California	90095	Recruiting
University of California, Irvine	Orange	California	92602	Recruiting
Stanford Hospital	Palo Alto	California	94305	Recruiting
University of South Florida - Carol and Frank Morsani Center of Advanced Healthcare	Tampa	Florida	33612	Recruiting
Karmanos Cancer Institute	Detroit	Michigan	48201	Recruiting
University of Minnesota Delaware Clinical Research Unit	Minneapolis	Minnesota	55414	Recruiting
Mayo Clinic	Rochester	Minnesota	55905	Recruiting
Columbia University Irving Medical Center	New York	New York	10032	Recruiting
Ohio State University	Columbus	Ohio	43221	Recruiting
Oregon Health & Science University (OHSU)	Portland	Oregon	97239	Recruiting
Temple University Hospital	Philadelphia	Pennsylvania	19140	Recruiting
UT Southwestern Medical Center	Dallas	Texas	75390	Recruiting
Houston Methodist Hospital	Houston	Texas	77030	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06626919, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 24, 2026 · Synced Apr 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06626919 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →